Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

Oncogene

Volumn 21, Issue 46, 2002, Pages 7011-7026

  Brantley, Dana M ^a   Cheng, Nikki ^a   Thompson, Erin J ^a   Lin, Qing ^a   Brekken, Rolf A ^b   Thorpe, Philip E ^c   Muraoka, Rebecca S ^a   Cerretti, Douglas Pat ^d   Pozzi, Ambra ^a   Jackson, Dowdy ^e   Lin, Charles ^a   Chen, Jin ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOPE HEART INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d AMGEN INC   (United States)

^e PFIZER INC   (United States)

Author keywords

Eph receptor tyrosine kinase; Ephrin; Soluble Eph receptor; Tumor angiogenesis; Vascular window model

Indexed keywords

EPHRIN A RECEPTOR; EPHRIN RECEPTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; TUMOR GROWTH;

ADENOMA, ISLET CELL; ANIMALS; ANTIGENS, CD31; CELL MOVEMENT; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; IN SITU NICK-END LABELING; LYMPHOKINES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPHA1; RECEPTOR, EPHA2; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18644379904     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205679     Document Type: Article

References (59)

1. Aaltomaa S, Lipponen P, Papinaho S and Syrjanen K. (1993). J. Cancer Res. Clin. Oncol., 119, 288-294.
2. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W and Klein R. (1999a). Genes Dev., 3, 295-306.
3. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W and Klein R. (1999b). Genes Dev., 13, 295-306.
4. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR and Folkman J. (1997). Proc. Natl. Acad. Sci. USA, 94, 861-866.
5. Aslakson CJ and Miller FR. (1992). Cancer Res., 52, 1399-1405.
6. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D. (2000). Nat. Cell Biol., 2, 737-744.
7. Bergers G, Javaherian K, Lo KM, Folkman J and Hanahan D. (1999). Science, 284, 808-812.
8. Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, Kittrel F, Medina D, Matrisian LM, Kerr LD and Yull FE. (2001). Mol. Biol. Cell., 12, 1445-1455.
9. Brantley DM, Yull FE, Muraoka RS, Hicks DJ, Cook CM and Kerr LD. (2000). Mech. Dev., 97, 149-155.
10. Brekken RA, Huang X, King SW and Thorpe PE. (1998). Cancer Res., 58, 1952-1959.
11. Chen J and Ruley HE. (1998). J. Biol. Chem., 273, 24670-24675.
12. Cheng N, Brantley D and Chen J. (2002). Cytokine and Growth Factor Reviews, 13, 75-85.
13. Daniel TO, Stein E, Cerretti DP, St John PL, Robert B and Abrahamson DR. (1996). Kidney Int. Suppl., 57, S73-S81.
14. Dankort DL and Muller WJ. (1996). Transgenic Models of Breast Cancer Metastasis. Kluwer Academic Publishers.
15. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M and Yancopoulos GD. (1994). Science, 266, 816-819.
16. Davy A, Gale NW, Murray EW, Klinghoffer RA, Soriano P, Feuerstein C and Robbins SM. (1999). Genes Dev., 13, 3125-3135.
17. Davy A and Robbins SM. (2000). EMBO J., 19, 5396-5405.
18. Easty DJ, Herlyn M and Bennett DC. (1995). Int. J. Cancer, 60, 129-136.
19. Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M and Bennett DC. (1999). Int. J. Cancer, 84, 494-501.
20. Folkman J. (1990). J. Natl. Cancer Inst., 82, 4-6.
21. Folkman J. (1994). J. Clin. Oncol., 12, 441-443.
22. Folkman J, Watson K, Ingber D and Hanahan D. (1989). Nature, 339, 58-61.
23. Gale NW and Yancopoulos GD. (1997). Cell Tissue Res., 290, 227-241.
24. Gale NW and Yancopoulos GD. (1999). Genes Dev., 13, 1055-1066.
25. Gerety SS, Wang HU, Chen ZF and Anderson DJ. (1999). Molecular Cell, 4, 403-414.
26. Goede V, Fleckenstein G, Dietrich M, Osmers RG, Kuhn W and Augustin HG. (1998). Anticancer Res., 18, 2199-2202.
27. Hanahan D. (1985). Nature, 315, 115-122.
28. Hattori M, Osterfield M and Flanagan JG. (2000). Science, 289, 1360-1365.
29. Holder N and Klein R. (1999). Development, 126, 2033-2044. Holzman LB, Marks RM and Dixit VM. (1990). Mol. Cell. Biol., 10, 5830-5838.
30. Holzman LB, Marks RM and Dixit VM. (1990). Mol. Cell. Biol., 10, 5830-5838
31. Huai J and Drescher U. (2001). J. Biol. Chem., 276, 6689-6694.
32. Huang Q, Shan S, Braun RD, Lanzen J, Anyrhambatla G, Kong G, Borelli M, Corry P, Dewhirst MW and Li CY. (1999). Nat. Biotechnol., 17, 1033-1035.
33. Kuehn R, Lelkes PI, Bloechle C, Niendorf A and Izbicki JR. (1999). Pancreas, 18, 96-103.
34. Laferriere J, Houle F, Taher MM, Valerie K and Huot J. (2001). J. Biol. Chem., 276, 33762-33772.
35. Li CY, Shan S, Huang Q, Braun RD, Lanzen J, Hu K, Lin P and Dewhirst MW. (2000). J. Natl. Cancer Inst., 92, 143-147.
36. Lin P, Buxton JA, Acheson A, Radziejewski C, Maisonpierre PC, Yancopoulos GD, Channon KM, Hale LP, Dewhirst MW, George SE and Peters KG. (1998). Proc. Natl. Acad. Sci. USA, 95, 8829-8834.
37. McBride JL and Ruiz JC. (1998). Nech. Dev., 77, 201-204.
38. Muraoka RS, Lenferink AE, Simpson J, Brantley DM, Roebuck LR, Yakes FM and Arteaga CL. (2001). J. Cell Biol., 153, 917-932.
39. Myers C, Charboneau A and Boudreau N. (2000). J. Cell Biol., 148, 343-351.
40. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL and Pasquale EB. (2000). Oncogene, 19, 6043-6052.
41. Owens RB, Smith HS and Hackett AJ. (1974). J. Natl. Cancer Inst., 53, 261-269.
42. Pandey A, Shao H, Marks RM, Polverini PJ and Dixit VM. (1995). Science, 268, 567-569.
43. Papenfuss HD, Gross JF, Intaglietta M and Treese FA. (1979). Microvasc. Res., 18, 311-318.
44. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS and Martin GR. (1992). Lab. Invest., 67, 519-528.
45. Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P and Hicklin DJ. (1999). Cancer Res., 59, 5209-5218.
46. Preziosi R, Sarli G, Benazzi C and Marcato PS. (1995) J. Comp. Pathol., 113, 301-313.
47. Radvanyi F, Christgau S, Baekkeskov S, Jolicoeur C and Hanahan D. (1993). Mol. Cell Biol., 13, 4223-4232.
48. Rockwell S. (1977). Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 31, 153-160.
49. Rockwell S. (1978). Br. J. Cancer Suppl., 37, 212-215.
50. Rockwell S. (1981). Cancer Res., 41, 527-531.
51. Van den Broecke C, Vleminckx K, De Bruyne G, Van Hoorde L, Vakaet L, Van Roy F and Mareel M. (1996). Clin. Exp. Metastasis, 14, 282-296.
52. Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ and Kinch MS. (1999). The Prostate, 41, 275-280.
53. Wang HU, Chen ZF and Anderson DJ. (1998a). Cell, 93, 741-753.
54. Weidner N. (1996). Angiogenesis and Breast Cancer. Kluwer Academic Publishers.
55. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G. (1992). J. Natl. Cancer Inst., 84, 1875-1887.
56. Weidner N, Semple JP, Welch WR and Folkman J. (1991) N. Engl. J. Med., 324, 1-8.
57. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J. (2000). Nature, 407, 242-248.
58. Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R and Kinch MS. (1999). Cell Growth Differ., 10, 629-638.
59. Zelinski DP, Zantek ND, Stewart JC, Irizarry AR and Kinch MS. (2001). Cancer Res., 61, 2301-2306.